Skip to main content

PROCEPT BioRobotics Corp

PRCT
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0001588978

In the last 90 days, PROCEPT BioRobotics Corp insiders filed 1 open-market purchase and 3 sales; 253 institutions reported holding it in 13F filings for Q2 2026, worth $1.24B in total; no superinvestor holds it.

Q2 2023 vs. Q1 2023

How the institutions holding PROCEPT BioRobotics Corp changed between Q1 2023 and Q2 2023.

All holders in Q2 2023All holders in Q1 2023

13F holders of PRCT: Q1 2023 compared with Q2 2023
MeasureQ1 2023Q2 2023Change
Holders116120+4
Shares33.0M36.0M+3.02M (+9.2%)
Value$937.6M$1.27B+$333.4M (+35.6%)

New holders (26)

Institutions that held PROCEPT BioRobotics Corp at the end of Q2 2023 but not at the end of Q1 2023.

Institutions new to PRCT in Q2 2023
InstitutionSharesValue% of portfolio
American Century Companies Inc573,761$20.3M0.02%
Polar Asset Management Partners Inc.333,286$11.8M0.23%
Rhenman & Partners Asset Management AB279,000$9.86M1.04%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.223,553$7.90M0.02%
Jane Street Group, LLC122,726$4.34M0.01%
HSBC Holdings PLC73,366$2.59M0.00%
Lisanti Capital Growth, LLC61,730$2.18M0.30%
Brown Brothers Harriman & Co19,869$702.4K0.01%
PEAK6 Investments LLC18,642$659.0K0.06%
Janus Henderson Group PLC18,549$656.0K0.00%
Marshall Wace, LLP17,100$604.5K0.00%
Blair William & Co10,820$382.5K0.00%
Arizona State Retirement System10,712$378.7K0.00%
State Board of Administration of Florida Retirement System10,250$362.3K0.00%
DAFNA Capital Management LLC8,000$282.8K0.08%
Handelsbanken Fonder AB6,900$244.0K0.00%
Legato Capital Management LLC6,770$239.3K0.03%
Glass Jacobson Investment Advisors llc3,300$116.7K0.05%
O'Dell Group, LLC1,575$55.7K0.02%
Manchester Capital Management LLC60$2.12K0.00%
Signaturefd, LLC54$1.91K0.00%
Lindbrook Capital, LLC50$1.77K0.00%
Quadrant Capital Group LLC23$8140.00%
Allworth Financial LP10$3540.00%
Massmutual Trust Co FSB8$2830.00%
Crewe Advisors LLC4$1420.00%

Sold out (22)

Institutions that held PROCEPT BioRobotics Corp at the end of Q1 2023 and filed for Q2 2023 without it.